Newsroom

Sorted by: Latest

-

Split-Off of Liberty Live Holdings Approved at Liberty Media’s Special Meeting of Stockholders and Liberty Media Announces Final Terms of Reattribution

ENGLEWOOD, Colo.--(BUSINESS WIRE)--Split-Off of Liberty Live Holdings Approved at Liberty Media’s Special Meeting of Stockholders and Liberty Media Announces Final Reattribution Terms...
-

ProAmpac to Acquire TC Transcontinental Packaging from TC Transcontinental

CINCINNATI--(BUSINESS WIRE)--ProAmpac, a global innovator in flexible packaging and material science, announced today that it has signed a definitive agreement to acquire TC Transcontinental Packaging (“TCP”) from TC Transcontinental (TSX: TCL.A TCL.B) for US$1.51 billion (approximately CAD$2.1 billion), subject to customary adjustments for debt and debt-like items, cash, and net working capital. TCP generated approximately US$1.2 billion in revenue during the last 12 months ended July 27, 2025...
-

The Global Shape Memory Materials Market Report 2026: Technology Trends and Innovation Roadmap Through 2036 and 39 Profiles with Product Portfolios and Strategic Directions - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "The Global Shape Memory Materials Market 2026-2036" report has been added to ResearchAndMarkets.com's offering. The Global Shape Memory Materials Market 2026-2036 delivers an authoritative, data-driven analysis of one of advanced materials science's most dynamic sectors. This comprehensive market research report examines shape memory alloys (SMAs), shape memory polymers (SMPs), shape memory ceramics (SMCs), and emerging hybrid material systems that are revolutioniz...
-

Genome Editing Drugs Market Landscape Report 2025 with Spotlight on Casgevy - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Genome Editing Drugs Landscape" report has been added to ResearchAndMarkets.com's offering. This report investigates the impacts and development of Genome Editing therapies within the pharmaceutical industry from the standpoint of drug development. It provides a high-level analysis of key trends and movements within the industry via regulatory, clinical, and market-based analysis, allowing you to discern the large-scale changes within the market and how best to piv...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust FactorFX UCITS ETF 05.12.2025 FXGB LN IE00BD5HBR05 37,992.00 GBP 738,580.68 25.938  ...
-

NeoGenomics to Present Real-World Study on Comprehensive Genomic Profiling in Myeloid Malignancies at ASH 2025

FORT MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics will present new data at ASH on how comprehensive genomic profiling supports diagnosis and treatment decisions in myeloid malignancies....
-

AI is Reshaping Online Shopping, with 30% of Consumers Willing to Let an AI Agent Complete Their Purchases, New Contentsquare Survey Finds

NEW YORK--(BUSINESS WIRE)--AI is becoming an integral part of how people shop online, and new research from Contentsquare, an AI-first analytics platform, shows that consumers are increasingly receptive to AI that helps them make more confident, informed decisions. Shoppers are turning to the technology for clarity, efficiency, and support, and 30% say they would be willing to let an AI agent actually complete a purchase on their behalf, signaling a growing openness to more advanced forms of AI...
-

Harmony Biosciences Presents Clinically Meaningful Open-Label Extension Study Effectiveness Data for EPX-100 in Dravet Syndrome

PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY), today announced the presentation of initial open-label extension (OLE) data from the company’s ongoing Phase 3 ARGUS trial investigating EPX-100 (clemizole hydrochloride) for the treatment of Dravet syndrome (DS), which showed clinically meaningful reductions in seizure activity in participants with DS along with a favorable benefit-risk profile. The data from poster #3.353 will be presented at the Americ...
-

Connected Drug Delivery Devices Market Industry Trends Forecasts 2025-2035: Wearable Injectors Lead, Subcutaneous Delivery Dominates, and 30 Add-On Sensors Drive European Startup Innovation - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Connected Drug Delivery Devices Market Industry Trends and Global Forecasts to 2035: Distribution by Type of Device, Mode of Connectivity, Route of Administration, Therapeutic Area and Geographical Region" report has been added to ResearchAndMarkets.com's offering. The Connected Drug Delivery Devices Market is valued at USD 4.4 billion in 2025, to USD 12.7 billion by 2035, at a CAGR of 10.1% during the forecast period, till 2035. Currently, a significant proportion...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust FactorFX UCITS ETF 05.12.2025 FTFX IE00BD5HBQ97 63,402.00 USD 1,630,142.39 25.711  ...